Waldenstrom’s macroglobulinemia (WM) is a rare type of cancer that begins in the white blood cells.The abnormal white blood cells produce a protein that accumulates in the blood, impairs circulation and causes complications. It continues to be a clinical challenge for treating physicians as complete remissions and prevention of relapse are few in spite of all the therapeutic tools that are currently available.  Besides treatment aspects, correct diagnosis of WM often poses a challenge.

We are talking to the Clinical Director at Bing Center for Waldenström Macroglobulinemia, Dr. Jorge J. Castillo about WM management touching upon diagnosis, when not to get treated, current clinical trials and more. Joining us bringing in the patient perspective is patient advocate and IWMF Trustee, Peter DeNardis. This talk was recorded on October 29, 2022 in collaboration with Curetalks with Cellectar.

Click the link below to view the video:
https://www.youtube.com/watch?v=3LeizRXeE_A